Specially in women, BRCA1 or BRCA2 mutations result in a 57-65% or 45-55% risk of developing breast cancer by age 70 years, and a lifetime risk of 39-44% or 11-18% of developing ovarian cancer, respectively [1]. This evidence concerns the gene BRCA2 and ovarian carcinoma.